Delivery Order SPE2DR25D2104-SPE2DR26F3NCL
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $21,777.56, is for the delivery of Cyanocobalamin 500 MCG sprays. This is a firm fixed-price delivery order contract with a completion date of March 13, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,810.21 to AmerisourceBergen Drug Corp for the supply of Cyanocobalamin 500 mcg sprays. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 2, 2025, and was awarded on August 29, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $1,749.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566769117 - Cyanocobalamin 500 MCG Sprays, with a completion date of December 20, 2024. This is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CYANOCOBALAMIN 500 MCG SPRAYS, with a ceiling value of $7,195.49 and a period of performance through May 29, 2025. The contract is not set aside and was awarded on May 28, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB24FMCBC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,331.20 firm fixed-price delivery order is for the supply of 4565891635 - Cyanocobalamin 500 MCG Sprays. The contract has an ultimate completion date of September 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for $13,113.19 to supply 4,565,135,586 units of Cyanocobalamin 500 MCG sprays. The order is a firm fixed-price contract with a completion date of July 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through 2025. This IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of cyanocobalamin 500 mcg sprays. The contract has a firm fixed price ceiling value of $2,034.15 and runs through August 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,296.85 by the Defense Logistics Agency's Medical Supply Chain on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The award...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,038.14 by the Defense Logistics Agency's Medical Supply Chain on September 27, 2025. This firm fixed-price contract, designated as a non-competitive delivery order without set-aside, is scheduled for ultimate completion by September 29, 2025. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,551.76 by the Defense Logistics Agency's Medical Supply Chain on June 21, 2025, with a completion date of June 23, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) vehicle. The award demonstrates the company's continued role as a critical pharmaceutical and medical...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NCLDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,137.86 by the Defense Logistics Agency on November 3, 2025, for the supply of Cyanocobalamin 500 MCG sprays. The contract carries a firm fixed price and is scheduled for completion by November 4, 2025. This award was made through open competition with no set-aside designation. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026, which authorizes the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally. The Defense Logistics Agency's Medical Supply Chain relies on AmerisourceBergen as a critical vendor for pharmaceutical procurement supporting military and veteran healthcare operations. Cyanocobalamin, a vitamin B12 formulation commonly used for treatment of deficiency conditions, represents one of many pharmaceutical products AmerisourceBergen delivers through its DLA contracts, which span diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The company's federal contracting history demonstrates consistent performance in fulfilling competitively awarded delivery orders across multiple therapeutic domains, positioning it as a key supplier within the Defense Health Agency's medical logistics infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/3/25 |